Stocksigma LogoStocksigma Logo

Krebs Biochemicals Schedules Board Meeting for Q2 FY27 Financial Results

Krebs Biochemicals & Industries Limited announced that its Board of Directors will meet on 29th Oct'26 to consider and adopt the unaudited financial

Krebs Biochemicals Schedules Board Meeting for Q2 FY27 Financial Results

Krebs Biochemicals & Industries Ltd 路 Intimation 路 29 Oct 2026, 5:30 am

Krebs Biochemicals Schedules Board Meeting for Q2 FY27 Financial Results Krebs Biochemicals & Industries Limited announced that its Board of Directors will meet on 29th Oct'26 to consider and adopt the unaudited financial results for the second quarter and half year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed from the close of business hours on 30th Sep'26 and will remain closed until 48 hours following the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Krebs Biochemicals & Industries Ltd

  • Krebs Biochemicals and Industries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 29 Oct 2026
  • Financial Results for the quarter ended 30.09.2026 路 29 Oct 2026
  • Outcome of the Board Meeting for consideration of unaudited financial results for the quarter ended 30.09.2026 路 29 Oct 2026
  • To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 29 Oct 2026
  • KREBS BIOCHEMICALS AND INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 29 Oct 2026
  • Scrutinizer Report of 34th AGM 路 30 Sept 2026
  • Outcome of 34th AGM 路 29 Sept 2026
  • The Company has enclosed herewith Notice of 34th AGM along with Annual Report FY 2025-26. 路 04 Sept 2026

All Krebs Biochemicals & Industries Ltd announcements